What dose of aspirin should be used in the initial treatment of Kawasaki disease?

被引：11
作者：
Ho, Luke Guo Yang [1 ,2 ,3 ]
Curtis, Nigel [2 ,3 ]
机构：
[1] Monash Univ, Monash Sch Med, Clayton, Vic, Australia
[2] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia
[3] Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Parkville, Vic, Australia
来源：
ARCHIVES OF DISEASE IN CHILDHOOD | 2017年 / 102卷 / 12期
关键词：
SALICYLATES; MANAGEMENT; DIAGNOSIS; OUTCOMES;
D O I：
10.1136/archdischild-2017-313538
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：1180 / 1182
页数：3
相关论文
共 22 条
[1]  
Amarilyo G, 2017, CLIN EXP RHEUMATOL S, V35, P103
[2]   Aspirin dose for the prevention of cardiovascular disease - A systematic review [J].
Campbell, Charles L. ;
Smyth, Susan ;
Montalescot, Gilles ;
Steinhubl, Steven R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (18) :2018-2024
[3]   Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease [J].
Dallaire, Frederic ;
Fortier-Morissette, Zoe ;
Blais, Samuel ;
Dhanrajani, Anita ;
Basodan, Dania ;
Renaud, Claudia ;
Mathew, Mathew ;
De Souza, Astrid M. ;
Dionne, Audrey ;
Blanchard, Joel ;
Saulnier, Harrison ;
Kaspy, Kimberley ;
Rached-d'Astous, Soha ;
Dandah, Nagib ;
McCrindle, Brian W. ;
Human, Derek G. ;
Scuccimarri, Rosie .
PEDIATRICS, 2017, 139 (06)
[4]   Management of Kawasaki disease [J].
Eleftheriou, D. ;
Levin, M. ;
Shingadia, D. ;
Tulloh, R. ;
Klein, N. J. ;
Brogan, P. A. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2014, 99 (01) :74-83
[5]  
Group TDTTS, 1992, NEW ENGL J MED, V325, P1261
[6]   ASPIRIN AND OTHER PLATELET-ACTIVE DRUGS - THE RELATIONSHIP BETWEEN DOSE, EFFECTIVENESS, AND SIDE-EFFECTS [J].
HIRSH, J ;
DALEN, JE ;
FUSTER, V ;
HARKER, LB ;
SALZMAN, EW .
CHEST, 1992, 102 (04) :S327-S336
[7]   Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes [J].
Kim, Gi Beom ;
Yu, Jeong Jin ;
Yoon, Kyung Lim ;
Jeong, Soo In ;
Song, Young Hwan ;
Han, Ji Whan ;
Hong, Young Mi ;
Joo, Chan Uhng .
JOURNAL OF PEDIATRICS, 2017, 184 :125-+
[8]   Sensorineural hearing loss and Kawasaki disease: A prospective study [J].
Knott, PD ;
Orloff, LA ;
Harris, JP ;
Novak, RE ;
Burns, JC .
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2001, 22 (05) :343-348
[9]   DETERMINANTS OF LOW SERUM CONCENTRATIONS OF SALICYLATES IN PATIENTS WITH KAWASAKI DISEASE [J].
KOREN, G ;
SCHAFFER, F ;
SILVERMAN, E ;
WALKER, S ;
DUFFY, C ;
STEIN, L ;
SURIA, D ;
SCHUE, S ;
THIESSEN, JJ ;
GELFAND, E ;
LAXER, R .
JOURNAL OF PEDIATRICS, 1988, 112 (04) :663-667
[10]   DECREASED PROTEIN-BINDING OF SALICYLATES IN KAWASAKI-DISEASE [J].
KOREN, G ;
SILVERMAN, E ;
SUNDEL, R ;
EDNEY, P ;
NEWBURGER, JW ;
KLEIN, J ;
ROBIEUX, I ;
LAXER, R ;
GIESBRECHT, E ;
BURNS, JC .
JOURNAL OF PEDIATRICS, 1991, 118 (03) :456-459
123